Deposition of cross-linked insoluble protein aggregates such as amyloid plaques is characteristic for Alzheimer's disease. Microglial activation by these extracullar deposits has been proposed to play a crucial role in functional degeneration as well as cell death of neurones. A sugar-derived post-translational modification of long-lived proteins, advanced glycation endproducts (AGEs), activate specific signal transduction pathways, resulting in the up-regulation of various proinflammatory signals such as cytokines [interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-a)] and inducible nitric oxide synthase (iNOS). Our goal was to study AGE-activated signal transduction pathways involved in the induction of proinflammatory effectors in the murine microglial cell line N-11. Chicken egg albumin-AGE (CEA-AGE), used as model AGE, induces nitric oxide (NO), TNF-a and IL-6 production. The AGE receptor, RAGE, and the transcription factor, nuclear factor kappa B (NF-jB), appear to be involved in all pathways, since a neutralizing RAGE antibody and a peptide inhibiting NF-jB translocation down-regulated NO, TNF-a and IL-6 production. NO and TNF-a, but not IL-6 production appear to be regulated independently, since NOS inhibitors did not decrease TNF-a secretion and a neutralizing TNF-a antibody did not reduce NO production, while employment of NOS inhibitors reduced significantly the secretion of IL-6. Inhibition of the MAP-kinase-kinase (MEK) and phosphatidylinositol 3-kinase (PI 3 K) pathway, but not that of mitogen-activated protein kinase-p38 (MAPK-p38), reduced NO, TNF-a and IL-6 significantly, suggesting that simultaneous activation of the first two pathways is necessary for the AGE-induced induction of these pro-inflammatory stimuli.
Microglia, the resident macrophages of the central nervous system (CNS), are present in the brain in a resting ramified state, secreting factors that assist growth and survival of neurones and astroglia (Kreutzberg 1996) . The most characteristic feature of microglia is their rapid activation in response to brain injury, infection, inflammation trauma or ischemia, producing a graded response. Activation of microglia is associated with cell transformation to phagocytes, capable of releasing substances such as oxygen radicals, nitric oxide, proteases and pro-inflammatory cytokines . The pro-inflammatory cytokines produced by the activated microglia also include interleukins IL-1b, IL-6, and tumour necrosis factor-alpha (TNF-a), which can cause cytotoxic or cytopathic effects in the CNS (Dickson et al. 1993) . Prolonged or excessive stimulation of microglia initiates an inflammatory cascade which contributes to several neurological diseases such as Alzheimer's disease (AD), Parkinson's disease (McGeer et al. 1993; Stoll and Jander 1999) , multiple sclerosis (Boyle and McGeer Amongst the candidates, present in the brain of the elderly, supposed to cause a strong inflammatory response in microglia, are sugar-derived advanced glycation endproducts (AGEs). The reactions of reducing sugars or sugar fragmentation products with free amino groups yields AGE, one of the most common non-enzymatic modifications of proteins. Subsequent rearrangements, oxidations and dehydrations yield a heterogeneous group of mostly coloured and fluorescent compounds, termed Maillard products or AGEs. Most notably, AGEs have been observed on long-lived proteins such as collagen and eye lens crystalline, and also in pathological protein deposits such as b-amyloid plaques in AD and b 2 -microglobulin deposits in haemodialysis patients Miyazaki et al. 1995) . Since they upregulate a variety of growth factors and cytokines such as interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-a) by a receptor-mediated mechanism, AGE-modified proteins are proposed to be involved in the aetiopathogenesis or progression of various age-related diseases, including AD, and complications of diabetes and haemodialysis (Colaco and Harrington 1994; Smith et al. 1994; Vlassara 1996) . In many experimental systems, nitric oxide (NO) has been shown to play an important role under both physiological and pathological conditions. Under physiological conditions, NO is involved in numerous functions, including neurotransmission, learning and memory, and ranging from intracellular signalling through necrotic killing of the cells and invading of pathogens to the involvement of NO in apoptosis (Bolanos et al. 1997; Law et al. 2001) . In summary, all of the AGE-inducible pro-inflammatory factors could contribute to inflammation-induced damage and therefore, a more detailed knowledge of their signalling pathways could assist in the development of novel antiinflammatory drugs.
Thus, the aim of our study was to investigate the effect of an AGE-modified model protein [chicken egg albumin-AGE (CEA-AGE)] on a, possibly receptor for AGEs (RAGE)-mediated, induction of NO synthesis in microglia, and the signal transduction cascade involved. Hence, specific inhibitors for p44/p42 mitogen-activated protein kinase (MAPK), p38 MAPK and phosphoinositol-3 kinase (PI 3 K) pathways, as well as different nitric oxide synthetase (NOS) inhibitors were used. In addition, the effects of these inhibitors on the production of TNF-a and IL-6 were also followed in order to assess the similarities or differences in their signalling pathways. Thirdly, a possible cross-talk among these pathways was investigated.
Materials and methods

Materials
Dulbecco's modified Eagle's medium (DMEM), fetal calf serum (FCS), glutamin, non-essential amino acids and penicillin/ streptomycin were purchased from Gibco BRL (Rockville, MD, USA). TNF-a and IL-6 'Quantikine' ELISA kits, recombinant murine TNF-a and anti-mouse TNF-a antibody were purchased from R & D Systems (Abingdon, UK). Piceatannol, genistein, aminoguanidine, L-NAME and L-NIL were obtained from Sigma Aldrich (St. Louis, MO, USA) and all the other inhibitors from Calbiochem (Bad Soden, Germany). Anti-RAGE IgG and IgM antibodies were a gift from Dr B. Weigle (TU Dresden, Germany), and monoclonal mouse anti-RAGE antibody from Dr L. Denner (Texas Biotechnology Corporation, USA). Protein A Sepharose CL-4B bead suspension was obtained from Amersham Pharmacia Biotech (Freiburg, Germany). Antibodies against the non-phosphorylated and phosphorylated forms of p44/42 MAPK and p38 MAPK, as well as the positive controls, were purchased from Cell Signalling Technology (Beverly, MA, USA). The PhosphoPlus Ò Akt Antibody Kit, which detects phosphorylation at Ser473, was used for determination of Akt phosphorylation (New England Biolabs, Schwalbach, Germany). DAB and ABC Elite kits were obtained from Vector (Burlingame, CA, USA). Dialysis membranes (ZelluTrans, pore size 25 Å ) were purchased from Roth, Germany. Other chemicals were obtained from Sigma Aldrich.
Production of CEA-AGEs
AGEs were produced by incubation of chicken egg albumin (CEA) at a concentration of 1 mM with 1 M glucose in 100 mM phosphate buffer (PB), pH 7.4, at 50°C for 6 weeks. Since a steady and nearly linear increase in both fluorescence (370 nm excitation/440 nm emission) and absorbance at 400 nm was observed during the 6 weeks and the increase thereafter was only marginal, the CEA was assumed to be maximally modified. Unbound sugars were removed by dialysis with 5 · 2 L distilled water. The model-AGEs were lyophilized and resuspended in phosphate-buffered saline (PBS), pH 7.4, as 1 mM stock solution.
Endotoxin assay All preparations were tested for bacterial contamination using the chromogenic Limulus Amebocyte Lysate assay according to the manufacturer's specifications (QCL-1000, Bio-Whittaker Inc., Walkerville, MD, USA). Endotoxin levels for all Ab preparations and CEA-AGEs were less than 1 endotoxin U/mg protein.
Cell culture
Microglia cells (N-11 cell line) were a gift from Dr Paola RicciardiCastagnoli (Centre of Cytopharmacology, Milan, Italy). Cells were seeded onto 96-well tissue culture plates at a density of 5 · 10 4 cells per well and grown for 24 h in DMEM/10% FCS, supplemented with penicillin/streptomycin (100 U/mL, 100 lg/mL) and L-glutamine (2 mM) at 37°C, 5% CO 2 . The cell culture medium was then replaced with fresh serum-free medium for another 24 h to minimize the interference of growth factors in the serum with signal transduction. For NO determination, the N-11 cells were (i) preincubated with different inhibitors for 60 min prior to addition of CEA-AGE, (ii) co-incubated with CEA-AGE, or (iii) the inhibitors were added at different time points after application of CEA-AGE. In all these cases, the cells were incubated with CEA-AGE for 24 h. For TNF-a and IL-6 determination the N-11 cells were co-incubated with CEA-AGE and inhibitors for 24 h. CEA-AGE was used at the concentration of 5.0 lM.
NO determination
After 24 h of treatment the cell culture supernatant fluids were collected for estimation of NO production. Nitrite concentration in the supernatant fluid was determined in 50 lL samples to which 50 lL of Griess Reagent were added. After 15 min, formed colour was measured in an ELISA plate reader at 540 nm with a reference at 630 nm.
Determination of cytokines
After a 24 h co-incubation, cell culture supernatant fluids were centrifuged, transferred to a fresh plate and stored at )20°C until use. The concentrations of TNF-a and IL-6 were measured using commercially available 'Quantikine' ELISA kits according to the manufacturers' instructions.
Immunoprecipitation
Immunoprecipitation was performed following a standard procedure (Harlow and Lane 1999) . To immunoprecipitate the RAGE fraction from N-11 cells, 80 lL of the whole cell lysate [lysis buffer: 50 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.1% sodium dodecyl sulfate (SDS), 0.5% deoxycholic acid, 1% Igepal, 1 mM phenylmethylsulfonyl flouride, 10 lg/mL aprotitin, 10 lg/mL leupeptin] were incubated with 10 lL of the polyclonal anti-RAGE IgM antibody on ice for 1 h. After adding 100 lL of protein A Sepharose CL-4B bead suspension [10% v/v in 2 · immunoprecipitation buffer (IPB): 100 mM Tris-HCl, pH 7.5, 0.2% SDS, 1% doexycholic acid, 2% Igepal, 300 mM NaCl, 4 mM EDTA], the incubation was continued at 4°C for 1 h with rocking. The beads were collected by centrifugation at 10 000 g for 15 s at 4°C and thoroughly washed three times with 1 · IPB. The precipitated proteins were eluted in 50 lL reducing SDS-electrophoresis sample buffer by heating to 95°C for 10 min; 5 lL of the isolated material were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) followed by western blotting (described below), and detected with the monoclonal-mouse anti-RAGE antibody (1 : 1000).
Western blot
Serum-starved cells were treated with (i) CEA-AGE alone for 10, 20 and 40 min, or (ii) CEA-AGE co-incubated with PD98059 for 10 min, chilled at 4°C, washed with ice-cold PBS and solubilized with lysis buffer (50 mM HEPES, pH 7.4, 150 mM NaCl, 10 mM EDTA, 10 mM Na 2 P 2 O 7 , 100 mM NaF, 2 mM vanadate, 1 mM phenylmethylsulfonyl flouride, 10 lg/mL aprotitin, 10 lg/mL leupeptin, 1% Triton X-100) for 20 min at 4°C. The proteins were separated by SDS-PAGE and transferred by semi-dry blotting to polyvinyldifluoride (PVDF) membranes. The membranes were soaked in blocking buffer (Rotiblock, Roth, Germany) and then incubated overnight with primary antibodies (10% Rotiblock in tween 20(T)-Tris-buffered saline). After stringent washing, proteins were detected using horseradish peroxidase-linked secondary antibodies. The colour was developed with diamino-benzidine (DAB) staining using the ABC Elite Kit.
Data analysis
All experiments were carried out in triplicate and each experiment was repeated at least three times. Statistical analysis of the results was carried out by Student's t-test and post hoc ANOVA. Statistical significance was established at a p-value < 0.05 (*) or < 0.01 (**), respectively.
Results
Selection of optimal inhibitor concentrations
All the inhibitors used and the RAGE antibody were tested in N-11 cells at five different concentrations. The concentrations of inhibitors, shown in Table 1 , were selected according to the recommendations given by the manufacturer, and were in all cases well above the IC 50 value for their target enzyme. At these concentrations, cell viability was not compromised during the experiments (data not shown).
RAGE detection in N-11 cells
In order to investigate the role of RAGE in signal transduction of CEA-AGE in N-11 cells, we first had to prove that RAGE is present in this cell line. Since the level of RAGE was too low to detect directly, the N-11 cell lysate was first subjected to immunoprecipitation with the polyclonal RAGE IgM antibody. The immunoprecipitated proteins were analysed by western blot using the monoclonal RAGE IgG antibody, and a band corresponding to the molecular weight for RAGE was detected (Fig. 1) .
NO production
As an initial step to study the regulation of inducible nitric oxide synthase (iNOS) expression and NO production, doseand time-response curves for AGE-induced expression of iNOS and NO production were determined. In the present study, CEA-AGE induced NO production in a dose-dependent manner when applied at concentrations between 1 and 10 lM (Fig. 2a ). We chose a working concentration for AGEs of 5 lM, since higher concentrations of AGE caused a decrease in cell viability (data not shown). With regard to the time dependence of NO production, we had previously shown that iNOS mRNA can be detected 4 h after exposure to AGEs, while iNOS protein is detectable after 4 h, constantly increases between 4 and 16 h, and remains stable between 16 and 24 h (Wong et al. 2001a) . Similarly to the previously published experiments, we show in this study that NO can first be measured after 6 h and continues to rise until 24 h (Fig. 2b) . To elucidate the involvement of signalling pathways and to determine at which time point they are important in the regulation of NO production, specific inhibitors of defined members of signal transduction cascades were applied at different time points before and after activation of N-11 cells with CEA-AGE.
RAGE antibodies
We tested two different monoclonal RAGE antibodies (IgG and IgM) on AGE-induced NO production. Since the RAGE IgM antibody had a 20% stronger inhibitory effect than the RAGE-IgG (data not shown), it was used for all further experiments. A strong inhibitory effect of the RAGE IgM antibody on NO production could be detected, which continuously decreased when the antibody was added at later time points (Fig. 3) , suggesting that AGE-RAGE interaction is a very early step in this signal transduction cascade. A maximal inhibition of 71.4 ± 2.4% could be achieved with a 60 min pre-incubation of N-11 cells with RAGE IgM antibody before application of CEA-AGE.
Tyrosine protein kinase inhibitors
Two specific tyrosine kinase inhibitors, genistein and piceatannol, were used to determine the role of protein tyrosine kinases in the signalling transduction pathway of AGEs. With genistein, the maximal inhibition (40%) of NO production was achieved with a 60 min pre-incubation of N-11 cells, while application at later time points reduced the inhibition from 20% to 30% (Fig. 4a ). Piceatannol, a preferential inhibitor of the protein tyrosine kinase Syk, showed a weak but time-dependent NO inhibition similar to that of genistein (Fig. 4b ).
Nuclear factor kappa B (NF-jB) inhibitors
To determine the involvement of NF-jB in AGE-induced NO production, the samples were incubated with a cellpermeable inhibitor peptide (NF-jB SN50), which contains the nuclear localization sequence (residues 360-369) of the transcription factor NF-jB p50 and inhibits its translocation to the nucleus, or with pyrrolidine dithiocarba-manate (PDTC), which is suggested to inhibit NF-jB via a (yet unknown) mechanism involving metal chelation. The NF-jB SN50 inhibitor peptide showed a strong inhibition of NO production when added simultaneously or in the first hour after AGE activation (about 60%) (Fig. 5a ), which suggests that NF-jB translocation is a very early event in the AGE-NO pathway. PDTC inhibited about 50% of NO production at all time points, which rather suggests an unspecific effect, e.g. on the enzymatic activity of the iNOS itself (Fig. 5b ).
p44/42 MAPK (ERK1/2) inhibitors PD 98059 and AG 126, a MEK1/2 and a p42MAPK/ERK2 inhibitor, respectively, inhibited the AGE-induced production of NO (Figs 6a and 6b) . The maximum degree of inhibition by PD 98059 and AG 126 could be observed up to 2 h after CEA-AGE activation, indicating that this pathway is rather more important in the later stages of signalling than RAGE and NF-jB.
p38 MAPK inhibitors SB 203580, a specific inhibitor for the p38 MAPK, was used to determine the role of this pathway in AGE-NO signalling. No inhibitory effect of SB 203580 was observed when it was used in concentrations between 0.1 and 1 lM.
Since the IC 50 value of SB 203580 for p38 MAPK is 0.3-0.5 lM, our data suggest that this kinase is most likely not involved in AGE signalling towards NO. As a positive control, we investigated whether SB 203580 can downregulate lipopolysaccharide (LPS)-induced NO production, previously demonstrated in BV-2 microglia cells (Watters et al. 2002) . When LPS (500 ng/mL) was applied in combination with 1 lM SB 203580, a significant reduction of NO production could be detected (data not shown), which proves that at the given concentration, SB 203580 can inhibit NO synthesis if it is mediated by the p38 MAPK pathway.
PI 3 K inhibitors
A 20-60% inhibition of CEA-AGE-induced NO production is observed when LY 294002 was used, a specific PI 3 K inhibitor (Fig. 7a) . The p38 MAPK inhibitor, SB 203580 (10 lM), inhibited AGE-stimulated NO release similar to the specific PI 3 K inhibitor LY 294002 SB (Fig. 7b) . This is most likely caused by the inhibitory effect of SB 203580 on a downstream member of the PI 3 K pathway, the phosphoinositide-dependent protein kinase 1, which occurs at concentrations above 2 lM (Lali et al. 2000) . 
NOS inhibitors
Since inhibitors of NOS inhibit its enzymatic activity directly, they should be effective in very late stages of AGE-induced NO production. For the inhibition of NOS, three inhibitors were used: aminoguanidine, an irreversible nNOS and iNOS inhibitor, L-NAME, a slowly reversible nNOS and iNOS inhibitor, and L-NIL, a selective iNOS inhibitor. Taking into consideration that expression of iNOS does not start earlier than 4 h after exposure to AGEs (Wong et al. 2001a) , it was expected that application of NOS inhibitors up to 4 h post CEA-AGE treatment would result in a similar time course of inhibition of NO production. This trend could be seen with all three inhibitors. An almost complete inhibition of NO production (90%) was achieved with aminoguanidine ( Fig. 8a) . L-NAME and L-NIL caused an 80 and 70% inhibition, respectively (Figs 8b and 8c). It was expected that aminoguanidine, being an irreversible inhibitor, would show a higher percentage of iNOS inhibition than L-NAME, but as there should not have been any activation of nNOS, the inhibitory effect of L-NIL was less than expected. Therefore, the specific nNOS inhibitor SMTC was also tested at a concentration of 1 lM (IC 50 ¼ 0.3 lM). However, SMTC had no effect on NO levels, ruling out the involvement of nNOS on AGE-induced NO production.
Effect of inhibitors on AGE-induced TNF-a production After a more detailed investigation of the pathways involved in AGE-NO signalling, further experiments were performed with the same signal transduction pathway inhibitors and TNF-a as the AGE-inducible specific readout. These experiments were also designed to determine whether drugs influencing specific pathways such as iNOS would also be able to down-regulate other AGE-induced inflammatory cascades, which could be helpful in selecting drug targets for an AGE-based anti-inflammatory treatment. TNF-a was measured in the cell culture medium after incubation of N-11 cells with CEA-AGE for 24 h. TNF-a release increased within the first 4 h and stayed at approximately the same level for up to 24 h (data not Time-dependent inhibition of NO production by phosphatidylinositol-3 kinase inhibitors. NO production is observed by the inhibition of PI 3 K, with the specific inhibitor LY 294002 (a) and SB 203580, the p38 MAPK inhibitor which at concentrations higher than 2 lM inhibits PI 3 K in a non-specific manner. The cells were incubated with CEA-AGE for 24 h and the signal transduction pathway inhibitors were added at different times. Data taken from five separate experiments (each done in triplicate) are expressed as mean ± SEM. Significant statistical difference between cells stimulated with AGEs or AGE + inhibitors are presented; **p < 0.01.
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shown). For comparison, all inhibitors in these experiments were added simultaneously with the CEA-AGEs, even though some substances had proved to be more potent NO inhibitors in the previous experiments when they were preincubated with the cells. About 40% of the TNF-a production could be blocked by addition of the IgM RAGE antibody. Inhibition of NFj-B-mediated signal transduction by the NF-jB SN50 peptide inhibited TNF-a production by around 40%, while PDTC had no effect. Tyrosine kinase inhibitors showed controversial effects on TNF-a production, genistein inhibiting about 50% of TNF-a synthesis while piceatannol had no inhibitory effect. Inhibition of p44/42 MAPK pathway by PD 98059, affecting MEK1/2, blocked the synthesis of TNF-a totally. Inhibition one step downstream in this MAPK pathway by AG 126, blocking p42MAPK/ERK2 phosphorylation, resulted in a small, but also significant inhibition of TNF-a synthesis. The contribution of the PI 3 K pathway to the CEA-AGE-initiated TNF-a release was approximately 50%, whereas NOS inhibitors showed no effect on TNF-a production (Fig. 9a) . These data suggest that RAGE, the MAPK-NF-jB and PI 3 K pathways are (at least partially) involved in AGE signalling towards TNF-a.
The relationship between NO and TNF-a production
To investigate whether TNF-a is involved in the production of NO, we used recombinant mouse TNF-a and a mouse TNF-a neutralizing antibody. Recombinant mouse TNF-a, applied at a concentration of 0.05 to 1.5 ng/mL, did not stimulate NO production on its own (data not shown).
Similarly, the simultaneous addition of the TNF-a neutralizing antibody (ECD50 ¼ 0.2-0.6 lg/mL) to N-11 cells activated with CEA-AGE did not inhibit NO production (Fig. 9b ). In conclusion, TNF-a appears not to be involved in CEA-AGE-induced NO production.
Effect of inhibitors on AGE-induced IL-6 production IL-6 was also measured in the medium after 24 h coincubation of CEA-AGE using the same signal transduction pathway inhibitors as before. Similar to TNF-a, around 50% of IL-6 production could be blocked by the RAGE antibody. The NFj-B inhibitory peptide inhibited IL-6 production totally, while PDTC caused only 60% inhibition. Both tyrosine kinase inhibitors successfully inhibited the release of IL-6, genistein being extremely potent (90% inhibition). Involvement of the p44/42 MAPK signal transduction pathway in AGE-induced IL-6 synthesis was also observed. The effect of the PI 3 K pathway on TNF-a was approximately 50% (Fig. 10a) . A partial but significant effect of NO inhibitors on IL-6 production was also observed.
The relationship between NO and IL-6 production To define more closely the relationship between NO and IL-6 production, N-11 cells were activated with different concentrations of CEA-AGE, and IL-6 and NO production were determined simultaneously (Fig. 10b) . A high correlation (R 2 ¼ 0.8524) was observed between NO and IL-6 production. These data, and the observation that L-NAME, L-NIL and aminoguanidine inhibit around 30-50% of IL-6, suggest that not only RAGE, the MAPK-NF-jB, tyrosine kinase and PI 3 K pathways, but also NO is (at least partially) involved in AGE signalling towards IL-6. Fig. 9 The effect of different inhibitors on TNF-a production. TNF-a was measured in the medium after 24 h co-incubation of CEA-AGE with all inhibitors. The values were determined by ELISA, taken from three separate experiments (each done in duplicate) and are expressed as mean ± SEM. Significant statistical differences between the AGE-stimulated cells and AGE + inhibitors are presented; *p < 0.05, **p < 0.01 (a). The lack of TNF-a influence on NO production by use of anti-TNF-a neutralizing antibody (b). Nitrites were measured after 24 h of incubation of CEA-AGE with anti-TNF-a neutralizing antibody (0.1-10 lg/mL). Data taken from three separate experiments (each done in triplicate) are expressed as mean ± SEM. Fig. 10 The effect of different inhibitors on IL-6 production. IL-6 was measured in the medium after 24 h of co-incubation of CEA-AGE with all inhibitors. The values were determined by ELISA, taken from three separate experiments (each done in duplicate) and are expressed as mean ± SEM. Significant statistical difference between the AGEstimulated cell and AGE + inhibitors are presented; *p < 0.05, **p < 0.01 (a). Correlation between NO and IL-6 production (b). N-11 cells were incubated for 24 h, after which the medium was removed for nitrite and IL-6 determination.
Analysis of phosphorylation of signal proteins after CEA-AGE activation
The signalling pathways activated by CEA-AGE were also studied by western blot, in which phosphorylation of the MAPK family members, extracellular signal-related kinase (ERK or p44/42) and p38 MAPK after exposure to CEA-AGE, was determined. For analysis of the MAPK pathway, cells were treated with CEA-AGE in the absence or presence of PD 98059, a specific inhibitor for MEK (upstream of MAPK), for 10 min. Antibodies against the non-phosphorylated and the phosphorylated p44/42 proteins were used. Phosphorylation of p44/42 was higher in N-11 cells treated with CEA-AGE than in cells incubated with CEA-AGE plus PD 98059 (Fig. 11a) . In a further experiment, phosphorylation of p38 MAPK was analysed. For this purpose, cells were stimulated for 10, 20 or 40 min with CEA-AGE and analysed by western blot using antibodies against both the non-phosphorylated and phosphorylated forms of p38 MAPK. We were unable to detect any activation of p38 MAPK, supporting the negative results with the p38 inhibitor SB 203580 (Fig. 11b) . To determine whether CEA-AGE activates the PI 3 K-dependent cascade, we measured the downstream effector of PI 3 K, protein kinase B (PKB) or Akt. Cells were stimulated for 10, 20 and 40 min with CEA-AGE, and whole cell lysates were analysed by western blot using antibodies to non-phosphorylated and phosphorylated forms of Akt. Although inhibition of NO, TNF-a and IL-6 by the PI 3 K inhibitor LY 294002 was evident, no phosphorylation of Akt on its primary phosphorylation site (Ser 473) was observed (Fig. 11c) .
Discussion
The silent and chronic cerebral inflammation caused by betaamyloid senile plaques in AD results in long-lasting injury and finally cell death of neurones. Microglia are likely to have a pivotal role in inflammatory injury in AD, since their interaction with senile plaques causes the induction of a range of pro-inflammatory and cytotoxic products. This hypothesis is supported by data from various studies which suggest that the long-term use of non-steroidal anti-inflammatory drugs (NSAIDs), particularly non-salicylates, may help to prevent AD (in t' Veld et al. 2001) .
AGEs in amyloid plaques (Wong et al. 2001b ) may particularly contribute to the oxidative stress which occurs in AD, a presumed source of pro-inflammatory processes in the brain. Both microglia and astrocytes are known to synthesize and secrete a wide variety of molecules involved in inflammation, e.g. NO via iNOS, TNF-a and IL-6, which are all inducible by AGEs. The details of the AGE-relevant signal transduction pathways in glia cells, and the factors regulating the expression of the genes included, are still not well understood. Therefore, our approach was to prevent the AGE-triggered activation of N-11 cells by inhibition of selected components of signalling cascades, which was measured by both functional readouts (NO, TNF-a and IL-6) and determining phosphorylation of relevant kinase substrates along the tested pathways.
Initially, we had to prove that the AGE-reception is mediated via an interaction with a membrane receptor such as RAGE. We showed the expression of RAGE, in N-11 cells, by immunoprecipitation. The ligation of RAGE with pathologically relevant ligands (for example, AGEs) is suggested in the generation of cellular oxidant stress and activation of a Ras-MAPK pathway that eventually leads to the nuclear translocation of the transcription factor NF-jB (Huttunen et al. 1999) . Several AGE receptors and AGEbinding proteins have been identified, including p60 homologous to OST-48, p90 homologous to 80K-H, galectin-3 and scavenger receptor, but only RAGE was shown to be involved in signalling events (Thornalley 1998) . It is interesting that an increased expression of RAGE is found at places of high local AGE concentration, such as smooth muscle cells, inflammatory cells like monocytes and in podocytes of the kidney (Schmidt et al. 1996; Park et al. 1998; Tanji et al. 2000; Goova et al. 2001) . Thus, RAGE ligands can contribute to enhanced expression of the receptor, leading to the hypothesis that chronic AGE-RAGE interaction could amplify inflammatory processes in diabetes, but also in the brain of AD patients via such an autocrine loop (Bucciarelli et al. 2002) . However, the signalling Fig. 11 Phosphorylation of p44/42 MAPK, p38 kinase and Akt in AGE-activated N-11 microglia cells. N-11 cells were treated with CEA-AGE in the absence or presence of a specific inhibitor for MEK, PD98059 for 10 min, and cell lysates were analysed by western blot using antibodies to non-phosphorylated and phosphorylated MAPK p44/42 (a). The cells were stimulated for 10, 20 and 40 min with CEA-AGE and analysed by western blot using antibodies against both the non-phosphorylated and phosphorylated forms of p38 MAPK (b) and Akt (c).
pathways mediated by activation of these AGE-binding proteins are not well understood. Hence, the only partial reduction of AGE-stimulated NO, TNF-a and IL-6 release by the tested RAGE antibodies may also suggest that other receptors and/or internalized AGEs may also be involved in AGE-related N-11 activation.
One of the earliest biochemical events after the AGEtriggered activation of N-11 cells is transient activation of transmembrane and/or soluble cytoplasmic protein tyrosine kinases (PTKs). The inhibition of PTKs by genistein and piceatannol only significantly prevents IL-6 release, whereas NO and TNF-a appear to be regulated independently. The difference in signals by the PTK inhibitors might be attributed to the fact that genistein is not only a protein tyrosine kinase inhibitor but is also an isoflavonoid. The antioxidative potential of flavonoids was one of the earliest functions proposed for these compounds. The radical-scavenger properties of flavonoids range from scavenging superoxide anion, to hydroxyl, peroxyl, alkoxyl radicals and NO radical (Exner et al. 2001) . This could explain the high inhibition of TNF-a with genistein compared with the absence of an inhibitory effect with piceatannol. The inhibitory effect of PTK inhibitors on the production of IL-6 is consistent with results observed in monocytes and human fibroblasts activated with LPS (Beaty et al. 1994; Samamoto et al. 2002) . Since both tyrosine kinase inhibitors, genistein and piceatannol, inhibit the production of IL-6, we can speculate that the additional anti-oxidative potential of genistein as a flavonoid is not of importance in this pathway.
Activation of many receptors, as well as tyrosine kinases, propagates the signal along a specific transduction pathway including a transient activation of the evolutionarily conserved MAPKs signalling pathway. There are at least three distinct MAPK signal transduction pathways in mammalian cells, each named after the particular MAPK associated with it. These include the extracellular signal-regulated kinases p44/ERK1 and p42/ERK2 (also known as MAPKs), the cJun N-terminal kinases/stress-activated protein kinases (JNK/ SAPK) and the p38 kinases. Depending on stimulus and cell type, each MAPK follows its own distinct time course, which can vary extensively in magnitude and duration between cell types and depending on the stimulus (Alonso et al. 2003) . Activation of ERK has been observed in numerous cell types, while the activation of stress-activated protein kinases SAPK/JNK and p38 is more controversial. It has been found that in ARPE-19 retinal cells, AGEs activate ERK and JNK but not p38 MAPK (Treins et al. 2001) , in C6 glioma cells ERK, both JNK and p38 MAPK are activated , while AGE-stimulated THP-1 monocytes have activated ERK, p38 MAPK but not JNK (Yeh et al. 2001) . In the present study, we showed that CEA-AGE causes phosphorylation of ERK1/2 in N-11 microglia cells, and that the inhibition of ERK1/2 by PD 98059 results in a decrease of phosphorylated p44/p42. The consequential blockade of ERK1/2 activation significantly prevented the AGE-stimulated synthesis of NO, TNF-a and IL-6.
Involvement of the transmembrane PTK-dependent PI 3 K pathway in the investigated AGE-triggered signal transduction in microglia is supported by our data. The inhibition of NO production, as well as the reduction in TNF-a and IL-6-synthesis by the specific PI 3 K inhibitor LY 294002, identifies this pathway as a constituent of the signal cascade. However, we failed to verify the phosphorylation of Akt (protein kinase B), a downstream substrate in the PI 3 K pathway, on its preferred phosphorylation site (Ser 473) by western blot. This could mean that the quantity of phopshorylated Akt is lower than the detection limit of our system, or that another effector molecule is recruited by PI 3 K. One of the alternative pathways includes sigalling via a G-protein-coupled receptor and the subsequent stimulating G-protein that activates the phospholipase C, which cleaves PIP2 to 1,2-diacylglycerol and inositol-1,4,5-trisphosphate IP3. The IP3 interacts with a calcium channel in the endoplasmatic reticulum, releasing Ca 2+ into the cytoplasm (Krauss 2001) .
A ligand-and cell type-specific response is determined by an integration of all signals, transfer of transcription factors or transcriptionally-active kinases across the nuclear membrane, resulting in transcriptional regulation of gene expression. Plenty of evidence supports the involvement of NF-jB in inducing gene expression by AGE in different cell lines Neumann et al. 1999; Tanaka et al. 2000; Wu et al. 2002) . It has been observed by many groups that the AGE-triggered signal cascade in N-11 cells involves nuclear translocation of NFj-B, but there were obvious differences in the potency between the two NFj-B inhibitors in our study. The NFj-B SN50 inhibitor peptide specifically inhibits nuclear translocation of NFj-B, whereas inhibition of NFj-B by PDTC is suggested to involve some (as yet undefined) step where (chelatable) metals are involved. Very interestingly, the NFj-B SN50 inhibitor peptide was much more potent in down-regulating the production of NO and IL-6 than that of TNF-a, indicating that other NF-jB independent pathways are involved in the regulation of TNF-a gene expression.
Furthermore, the time-dependent NO inhibition of NF-jB by the NFj-B SN50 inhibitor peptide indicates that NF-jB translocation is a very early event, as is AGE-RAGE interaction and MAPK activation. The time course of inhibition of NO production with the NFj-B SN50 inhibitor peptide does not correlate with that of PDTC, sugesting a different mode of action. In addition, one report claims that PDTC has a unique reciprocal activity in inhibiting NF-jB and activating AP-1 (Kim et al. 2003) . This dual activity could explain the difference between the two inhibitors.
One of the transcriptional targets after AGE stimulation is iNOS. The accumulation of iNOS protein in situations where NO synthesis is prevented is a well recognized event and is thought to be due to the lack of negative feedback of NO upon iNOS transcription and/or translation (Assreuy et al. 1993; Griscavage et al. 1995; Peng et al. 1998) . The involvement of nNOS in NO synthesis in microglial cells activated by AGEs was excluded by the experiments with the specific nNOS inhibitor SMTC.
In addition, we investigated a mutual interference of the molecules secreted after AGE-stimulation. Since the inhibition of iNOS did not reduce the release of TNF-a, there was no evidence of a role for NO in AGE-mediated TNF-a induction. Furthermore, the application of a TNF-a neutralizing antibody did not reduce NO release of N-11 cells after AGE stimulation. The fact that application of recombinant TNF-a directly to N-11 cells failed to induce a measurable NO response proved this result. These data suggest that there is no measurable interaction between the two pathways. In contrast, IL-6 production was markedly reduced by iNOS inhibitors, indicating that NO serves as a second messenger in the AGE-IL-6 pathway.
The details of the signals and mechanisms that regulate iNOS, TNF-a and IL-6 gene expression in glial cells when stimulated with inducers other than AGEs are complex and not completely understood. Studies with various cells of the immune system have suggested multiple levels of regulation, transcriptional, post-transcriptional and post-translational (Lowenstein et al. 1993; Xie et al. 1993) . Transcriptional regulation of iNOS and TNF-a is complex, involving a number of transcription factors including NF-jB, AP-1, and various members of the C/EBR, ATF/CREB and STAT family (Lowenstein et al. 1993; Xie et al. 1993; Jongeneel 1995) . The activation of IL-6 is also mediated by several factors, including NF-jB, AP-1, nuclear factor IL-6 and multiple response element (Papassotiropoulos et al. 2001) . AGEs have been shown to activate those transcription factors demonstrated for NF-jB (Iwashima et al. 1999) , AP-1 (Simm et al. 1997) and STAT-1 (Huang et al. 1999) . However, NF-jB is a common motive in the promotors of iNOS, TNF-a and IL-6, which explains the multiple potency of the SN50 inhibitory peptide or other NF-jB inhibitors in each of the investigated pathways.
Very interestingly, the experiments where inhibitors were added at different time points to inhibit AGE-induced NO production suggest that both early and late signals are involved in this pathway. Signal transduction molecules such as RAGE and NF-jB are involved in 'early signalling' processes, since a difference in NO production can already be observed in application of inhibitors between 0 and 1 h after application of AGEs. If the inhibitor is given later, a certain degree of the signal has already irreversibly passed down the signal transduction chain. PI3K and MEK/MAPK also appear to be critical in 'later' stages of AGE-induced signalling, since they could still fully block the signal when they were applied between 2 and 4 h after the AGEs. Considering these obvious difference, it appears that AGE-RAGE interaction and NF-jB translocation activate a subsequent signal transduction chain, which then (after approximately 2 h) involves both the PI 3 K and MEK/MAPK pathways for finally activating iNOS expression and subsequent NO production. The MEK/MAPK pathway in particular might also be important in early and late signalling events, since phosphorylation of MAPK could already be observed after 10 min of incubation with AGEs (Fig. 11) .
In conclusion, AGE-mediated signals inducing the expression of the pro-inflammatory cytokines TNF-a and IL-6, as well as iNOS, in N-11 cells involve both RAGE and the p42/ p44 MAPK-NF-jB pathway as common parts of the signal transduction chain (Fig. 12) . Although our study could not completely analyse all the steps along the AGE-induced pathways, it might help in the search for interesting drug targets if the broad intention is to suppress AGE-induced proinflammatory signals. However, it must be borne in mind that all the intracellular targets along the AGE pathway, such as the investigated kinases and NF-jB, are not only involved in pathophysiologcal inflammatory signalling but also transmit a variety of cellular signals under normal cellular conditions. Therefore, it might be suggested that therapeutic drugs should rather act at the level of the receptor RAGE, e.g. by lowering AGE levels with AGE inhibitors or cross-link breakers (tenilsetam or ALT-711) (Asif et al. 2000) , or by application of (not yet developed) RAGE antagonists. 
